Skip to main content

Detail

  1. Home
  2. Forschung
  3. Researcher Profiles
  4. Researcher Profiles
  5. Detail
Karlheinz Hilber
Assoc. Prof. Dr. Karlheinz Hilber

Center for Physiology and Pharmacology (Division of Neurophysiology and Neuropharmacology)
Position: Associate Professor

T +43 1 40160 31230
karlheinz.hilber@meduniwien.ac.at

Keywords

Arrhythmias, Cardiac; Calcium Channels, L-Type; Cardiac Electrophysiology; Cardiomyopathy, Dilated; Muscular Dystrophy, Duchenne; Voltage-Gated Sodium Channels

Research group(s)

Research interests

  • Cardiac ion channel impairments in the diseased heart
  • Effects of drugs on cardiac ion channels

Techniques, methods & infrastructure

whole cell patch clamp technique, isolation of cardiomyocytes from neonatal and adult mouse and guinea pig hearts, human induced pluripotent stem cell- derived cardiomyocytes, muscular dystrophy mouse models, standard biochemistry and molecular biology 

Members of this research group have access to a cell culture, a standard biochemistry and molecular biology lab, and a patch clamp rig.

Grants

  • Cardiac calcium channel abnormalities in Duchenne Muscular Dystrophy (2017)
    Source of Funding: FWF (Austrian Science Fund), Stand-Alone Projects
    Principal Investigator
  • Voltage-gated ion channel dysfunction in dystrophic muscle (2010)
    Source of Funding: FWF (Austrian Science Fund), Stand-Alone Projects
    Principal Investigator
  • Cardiogenic substances (2009)
    Source of Funding: aws (Austria Wirtschaftsservice), PRIZE
    Principal Investigator
  • Ion channel plasticity in transforming skeletal muscle (2006)
    Source of Funding: FWF (Austrian Science Fund), Stand-Alone Projects
    Principal Investigator
  • Na channels in fast and slow skeletal muscle (2001)
    Source of Funding: FWF (Austrian Science Fund), Stand-Alone Projects
    Principal Investigator

Selected publications

  1. Rubi, L. et al., 2018. Calcium current properties in dystrophin�deficient ventricular cardiomyocytes from aged mdx mice. Physiological Reports, 6(1), p.e13567. Available at: http://dx.doi.org/10.14814/phy2.13567.
  2. Koenig, X. & Hilber, K., 2015. The Anti-Addiction Drug Ibogaine and the Heart: A Delicate Relation. Molecules, 20(2), pp.2208-2228. Available at: http://dx.doi.org/10.3390/molecules20022208.
  3. Koenig, X. et al., 2013. Enhanced currents through L-type calcium channels in cardiomyocytes disturb the electrophysiology of the dystrophic heart. AJP: Heart and Circulatory Physiology, 306(4), pp.H564-H573. Available at: http://dx.doi.org/10.1152/ajpheart.00441.2013.
  4. Koenig, X. et al., 2012. Anti-addiction drug ibogaine inhibits hERG channels: a cardiac arrhythmia risk. Addiction Biology, 19(2), pp.237-239. Available at: http://dx.doi.org/10.1111/j.1369-1600.2012.00447.x.
  5. Koenig, X. et al., 2011. Voltage-Gated Ion Channel Dysfunction Precedes Cardiomyopathy Development in the Dystrophic Heart M. Rota, ed. PLoS ONE, 6(5), p.e20300. Available at: http://dx.doi.org/10.1371/journal.pone.0020300.